F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months

Basel, 20 October 2021 Group sales up 8%1 at constant exchange rates (CER); 6% in Swiss francsPharmaceuticals Division sales grow 5% in the third quarter and are now in line with the prior year for

Related Keywords

Japan ,Germany ,United States ,Argentina ,Brazil ,China ,Russia ,Canada ,Switzerland ,America ,Swiss ,Nathalie Meetz ,Mabthera Rituxan ,Gazyva Gazyvaro ,Severin Schwan ,Sileia Urech ,Venclexta Venclyxto ,September Roche ,Actemra Roactemra ,Patrick Barth ,Karsten Kleine ,International Region China ,Genentech ,Pathology Lab ,World Health Organization ,Diagnostics Division ,International Region ,Molecular Lab ,Core Lab ,Pharmaceuticals Division ,Roche Group ,European Medicines Agency ,Pharmaceuticals Industry ,Priority Review ,Breakthrough Therapy Designation ,Eastern Europe ,Middle East ,Latin America ,North America ,Breakthrough Therapy Designations ,Delivery System ,Therapy Designation ,Roche Digital Pathology Open Environment ,Accu Chek Guide ,World Health Organization Model Lists ,Essential Medicines ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Annual Report ,Hoffmann ,Oche ,Announcement ,Ursuant ,Reports ,Strong ,Growth ,First ,Line ,Months ,Outlook ,021 ,Aised ,